ASK REDCHAT ANYTHING ABOUT BLACK DIAMOND THERAPEUTICS INC.
Black Diamond Therapeutics Inc. (NASDAQ: BDTX)
Listen to this Section
$1.85
+0.0350
(
+1.93% )
227.5K
Sign up for The Small Stocks Big Money Newsletter and receive free small-cap news and insights.
Clinical Trial Pipeline Stages
| Drug Name |
Stage |
| BDTX-1535DetailsCancer, Non-small cell lung carcinoma |
Phase 2 |
| BDTX-1535DetailsNon-small cell lung carcinoma, Cancer |
Phase 2 |
| BDTX-1535DetailsCancer, Glioblastoma |
Phase 1 |
| BDTX-4933DetailsCancer |
Phase 1 |
| BDTX-189 (EGFR HER2)DetailsSolid tumor/s, Cancer |
Failed |
Market Data
|
| Open |
$1.85 |
| Previous Close |
$1.81 |
| Volume |
227.5K |
| Market Cap |
$103.72M |
| Day Range |
$1.79 - $1.87 |
| 52 Week Range |
$1.60 - $4.94 |
| Shares Outstanding |
57.30M |
| Change % |
+1.93% |
| Net Change |
▲ 0.0350 |
| Insider Ownership |
-0.02% |
| Exchange |
NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) |
| IPO Year | 2020 |
| Country | United States |
| Underwriter | IPO Intelligence Only |
Insider Ownership Transactions
Total Amount Purchased:
-1,401,109.00
| Date |
Type |
Amount Purchased |
Purchaser |
| 2024-06-21 |
Sale |
-2011.00 |
Campbell Shannon |
| 2024-06-21 |
Sale |
-2887.00 |
Behbahani Ali |
| 2024-06-21 |
Sale |
-2301.00 |
Raman Prakash |
| 2024-06-06 |
Sale |
-30550.00 |
Menzel Garry E |
| 2024-06-06 |
Sale |
-30550.00 |
Behbahani Ali |
| 2024-06-06 |
Sale |
-30550.00 |
Campbell Shannon |
| 2024-06-06 |
Sale |
-30550.00 |
Raman Prakash |
| 2024-06-06 |
Sale |
-30550.00 |
Dhingra Kapil |
| 2024-06-06 |
Sale |
-30550.00 |
Kulkarni Samarth |
| 2024-04-12 |
Sale |
-61100.00 |
Raman Prakash |